ArticleThe oncologist2025

Efficacy outcomes between tarlatamab and real-world physicians' choice of therapies for previously treated extensive stage small cell lung cancer.

Jessie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.